Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
|
|
Cyteir Therapeutics, Inc. (CYT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/04/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/24/2022 |
3
| Sands Stephen H. (Director) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 02/07/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/16/2021 |
3
| Humphrey Jeffrey (Director) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| Droia Invest II SCSp (10% Owner) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| Zakrzewski Joseph S (Director) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| Novo Holdings A/S (10% Owner) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| Romberger Timothy (Director) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| Naesens Janwillem (Director) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| Hong Karen (Director) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| Bracken Racquel (Director) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| Molineaux Susan (Director) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| George Jean (Director) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| Venrock Associates VII, L.P. (10% Owner) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| Gaiero David G (Vice President, Finance) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| Secrist John Paul (Chief Scientific Officer) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| Gengos Andrew (Chief Business Officer) has filed a Form 3 on Cyteir Therapeutics, Inc. |
| 06/17/2021 |
3
| RENSCHLER MARKUS MD (See Remarks) has filed a Form 3 on Cyteir Therapeutics, Inc. |
|
|